Please ensure Javascript is enabled for purposes of website accessibility

Angela Yoon, DDS, appointed director of MUSC Hollings Center Center Biorepository and Tissue Analysis Shared Resource

CRBJ Biz Wire //December 11, 2023//

Angela Yoon, DDS, appointed director of MUSC Hollings Center Center Biorepository and Tissue Analysis Shared Resource

CRBJ Biz Wire //December 11, 2023//

Listen to this article

Angela. J. Yoon, D.D.S., has been appointed as director of the MUSC Hollings Cancer Center Biorepository and Tissue Analysis Shared Resource, effective Dec. 1; she will oversee a growing collection of cancer-associated biospecimens that allow researchers to translate biological discoveries into prevention, diagnosis and treatment of cancer.

A professor in MUSC’s James B. Edwards College of Dental Medicine in the Department of Biomedical and Community Health Sciences with a joint appointment in College of Medicine in the Department of Otolaryngology-Head and Neck Surgery, Yoon has been engaged in the translation of laboratory science into new molecular risk assessment strategies and in improving therapies for oral precancers and cancers. She has a background in public health, dentistry and oral medicine and has dedicated a considerable part of her career to the pathologic diagnosis and clinical management of oral mucosal lesions.

“We are honored that Dr. Yoon has accepted this appointment,” said MUSC Hollings Cancer Center director Raymond N. DuBois, M.D., Ph.D. “Her vast leadership experience as a clinician-scientist and her interest in mentoring investigators will support Hollings Cancer Center as we work toward our goal of becoming an NCI-designated Comprehensive Cancer Center in five years.”

Yoon is investigating the prognostic utility of microRNA-based markers for oral cancer patients. She is also currently leading a clinical trial evaluating the efficacy of an immunomodulatory agent for oral cancer in a neoadjuvant setting. In collaboration with other MUSC investigators, Yoon is developing a prophylactic cancer vaccine using tumor-infiltrating lymphocytes harvested from patients who have been treated with immunotherapy prior to surgery.

Yoon came to Hollings from Columbia University Medical Center in 2022, where she served as a dentist, pathologist, researcher and faculty member for 16 years. Board certified by the American Board of Oral and Maxillofacial Pathology, Yoon completed her residency at NewYork-Presbyterian / Columbia University Irving Medical Center, received her D.D.S. from Columbia University, her Master of Public Health and Master of Medical Sciences and Bachelor of Arts from Boston University.